Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

HEXO (TSX:HEXO) Is Now a Top Marijuana Stock

Published 2019-03-19, 07:36 a/m
Updated 2019-03-19, 08:07 a/m
HEXO (TSX:HEXO) Is Now a Top Marijuana Stock

HEXO (TSX:HEXO) Is Now a Top Marijuana Stock

HEXO (TSX:HEXO) Is Now a Top Marijuana Stock

The marijuana industry is in the midst of an impressive comeback. After crashing post-legalization, the Canadian Marijuana Index is now up 53% year to date. One company that has been making headlines for all the right reasons is HEXO (TSX:HEXO).

In 2019, the company has surged almost 90% and is among the big winners of the year. In the past week alone, the company’s share price has jumped almost 10%. Why? It has been a transformative week for the company.

Prior to releasing strong second-quarter results, the company announced a deal to acquire Newstrike Brands.

Why is the Newstrike Brands deal a good move? Let’s start with the basics. HEXO has agreed to acquire Newstrike in an all-stock transaction. Newstrike shareholders will receive 0.06332 of a HEXO common share in exchange for each Newstrike share they hold. Although I am not a fan of these types of all-stock transactions, HEXO does not have a history of diluting shareholders on a regular basis.

One of the knocks against HEXO was that it was a regional play. Its distribution was largely dependent on the province of Quebec. Although it had distribution agreements in Ontario, it was not as diversified as some of the larger industry players. This all changed with the Newstrike deal.

The combined entity will have distribution agreements in eight provinces, significantly expanding the company’s market reach. It is also expected that the deal will enable HEXO the capacity to produce approximately 150,000 kg annually. This is a 38% increase from previous peak capacity production of 108,000 kg annually. This vaults it ahead of companies such as OrganiGram Holdings and Cronos Group.

As with any acquisition, there are expected synergies to be had. HEXO has pegged these synergies at approximately $10 million annually, which is considerable for a company of this size.

Strong second quarter In the second quarter, HEXO grew revenues by 143% over the first quarter of 2018 and by 13.74 times the first quarter of 2017. This is explosive growth — better than the industry leaders. It is worth noting, however, that revenue missed analysts’ estimates by 4.41%. That’s not a big miss, but it marks the fifth consecutive quarter in which it missed expectations. The company also posted a $0.05-per-share loss, missing by a penny.

Adult use is the main growth driver for HEXO, with sales in the segment increasing by 200% over the previous quarter. Interestingly, revenue per gram sold increased by 7% from the first quarter of 2019. This bucked a recent trend in which revenue sold per gram in the industry was declining. Does this mean prices are stabilizing? As other companies report, investors will get a better idea. It was certainly an encouraging sign.

Foolish Takeaway HEXO is starting to position itself as one of the top marijuana companies in the country. It has an oft-forgotten joint venture with Molson Coors and has taken a cautious approach to production expansion. The company is also cheap when compared to its peers. It has a forward price-to-sales ratio of 5.9 times 2020 revenue estimates. When compared to industry leader Canopy Growth, which is trading at 25 times 2020 sales, HEXO is cheap.

Fool contributor Mat Litalien has no position in any of the stocks mentioned. The Motley Fool owns shares of Molson Coors Brewing.

The Motley Fool’s purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool Canada’s free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. Motley Fool Canada 2019

This Article Was First Published on The Motley Fool

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.